Andropause: an old concept in new clothing.
Morley JE - Clin Geriatr Med - 01-AUG-2003; 19(3): 507-28
From NIH/NLM MEDLINE
NLM Citation ID:
14567004 (PubMed)
Full Source Title:
Clinics in Geriatric Medicine
Publication Type:
Journal Article; Review; Review, Tutorial
Language:
English
Author Affiliation:
GRECC, VA Medical Center, Division of Geriatric Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA. morley@slu.edu
Authors:
Morley JE; Perry HM 3rd
Number of References:
141
Abstract:
There is increasing evidence that the common condition of hypogonadism in older men when associated with symptoms responds well to testosterone replacement. Over the last few years there has been a marked increase in the awareness and treatment of the andropause [137]. Long-term side effects of testosterone are uncertain with only eight people over 50 years having been studied for 10 years [138]. Testosterone needs to be considered a quality-of-life drug, similar to sildenafil, and at present it should be used only if it produces symptomatic improvement. There is a need for a men's health study to determine the long-term efficacy and safety of testosterone replacement in older persons.
Major Subjects:
- Aging / * physiology
- Climacteric / drug effects / * physiology
- Testosterone / blood / * physiology / therapeutic use
Additional Subjects:
- Aged
- Humans
- Male
- Middle Aged
Chemical Compound Name:
58-22-0(Testosterone)